Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRights &iss. Regulatory News (RIII)

Share Price Information for Rights &iss. (RIII)

Share Price is delayed by 15 minutes
Get Live Data
2,190.00    10.00 (0.46%)
Bid:
2,160.00
Ask:
2,220.00
Spread: 60.00 (2.778%)
Market Cap: £103.34m
RIII Live PriceLast checked at - London Stock Exchange

Intraday Rights &iss. Share Chart

Update note from QuotedData

6 Feb 2025 15:40

RNS Number : 2378W
Rights and Issues Inv. Trust PLC
06 February 2025
 

Rights and Issues Investment Trust - Update from QuotedData

6th February 2025

Normal programming to resume

The first nine months of 2024 provided signs of a return to normality in the UK. With inflation falling steeply, the Bank of England was able to begin its interest rate-cutting cycle, while a steady pickup in growth provided a sense of optimism that had long been absent from the market. The Rights and Issues Investment Trust (RIII) responded in kind, delivering a shareholder total return of 17% to 30 September 2024. Unfortunately, this momentum slowed over the latter part of the year as investors fled UK small caps, particularly AIM (Alternative Investment Market) stocks, in advance of the budget, and yields climbed on both UK government bonds (gilts) and US treasuries, back towards cycle highs.

Although frustrating for investors, we believe the conditions that drove the first half recovery remain in place, and the recent weakness should not detract from the generally positive outlook for the UK, and RIII in particular. Market activity has finally begun to pick up as investors capitalise on historically cheap valuations and we believe that for active, high-conviction managers like RIII's, the opportunity to outperform in the coming years has arguably never been better.

Full Research:

https://quoteddata.com/research/rights-and-issues-investment-trust-normal-programming-to-resume-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Rights and Issues Investment Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZGGZKVLGKZM
Date   Source Headline
19th Sep 202512:45 pmRNSNet Asset Value(s)
18th Sep 202511:49 amRNSNet Asset Value(s)
17th Sep 20251:07 pmRNSNet Asset Value(s)
16th Sep 202511:47 amRNSNet Asset Value(s)
15th Sep 202512:09 pmRNSNet Asset Value(s)
12th Sep 20253:21 pmRNSNet Asset Value(s)
11th Sep 202512:16 pmRNSNet Asset Value(s)
10th Sep 202511:25 amRNSNet Asset Value(s)
9th Sep 202512:04 pmRNSNet Asset Value(s)
8th Sep 20252:51 pmRNSNet Asset Value(s)
5th Sep 202511:33 amRNSHolding(s) in Company
5th Sep 202510:14 amRNSNet Asset Value(s)
4th Sep 202511:46 amRNSNet Asset Value(s)
3rd Sep 202510:45 amRNSNet Asset Value(s)
2nd Sep 202511:35 amRNSNet Asset Value(s)
1st Sep 202511:29 amRNSNet Asset Value(s)
29th Aug 202511:05 amRNSNet Asset Value(s)
28th Aug 202511:30 amRNSNet Asset Value(s)
27th Aug 202510:33 amRNSNet Asset Value(s)
26th Aug 202510:57 amRNSNet Asset Value(s)
22nd Aug 202511:04 amRNSNet Asset Value(s)
21st Aug 202511:24 amRNSNet Asset Value(s)
20th Aug 20251:18 pmRNSNet Asset Value(s)
19th Aug 202511:45 amRNSNet Asset Value(s)
18th Aug 202511:10 amRNSNet Asset Value(s)
15th Aug 202511:31 amRNSNet Asset Value(s)
14th Aug 202511:22 amRNSNet Asset Value(s)
13th Aug 202511:58 amRNSNet Asset Value(s)
12th Aug 202511:18 amRNSNet Asset Value(s)
11th Aug 202510:45 amRNSNet Asset Value(s)
8th Aug 20253:25 pmRNSNet Asset Value(s)
7th Aug 202510:46 amRNSNet Asset Value(s)
7th Aug 20257:02 amRNSDividend Declaration
7th Aug 20257:00 amRNSHalf-year Report
6th Aug 202512:52 pmRNSNet Asset Value(s)
5th Aug 202511:25 amRNSNet Asset Value(s)
4th Aug 202511:16 amRNSNet Asset Value(s)
1st Aug 202512:05 pmRNSNet Asset Value(s)
31st Jul 202511:13 amRNSNet Asset Value(s)
30th Jul 202510:26 amRNSNet Asset Value(s)
29th Jul 202510:56 amRNSNet Asset Value(s)
28th Jul 202512:20 pmRNSNet Asset Value(s)
25th Jul 202512:21 pmRNSNet Asset Value(s)
24th Jul 202512:42 pmRNSNet Asset Value(s)
23rd Jul 20259:52 amRNSNet Asset Value(s)
22nd Jul 202510:37 amRNSNet Asset Value(s)
21st Jul 20251:29 pmRNSNet Asset Value(s)
18th Jul 202511:44 amRNSNet Asset Value(s)
17th Jul 202511:50 amRNSNet Asset Value(s)
16th Jul 202511:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.